Showing results (1981-1990 of 2,308) with videos related to
Sort By:
Pageof 231
Animal Genetics|January 27, 2005
Localizing the X-linked orange colour phenotype using feline resource familiesR A Grahn, B M Lemesch, L V Millon, et al.Neuropsychologia|September 24, 2004
A neuropsychological investigation of male premutation carriers of fragile X syndromeCaroline J Moore, Eileen M Daly, Nicole Schmitz, et al.Acta Oncologica (Stockholm, Sweden)|December 19, 2012
Outcomes in men with large prostates (≥ 60 cm(3)) treated with definitive proton therapy for prostate cancerLisa McGee, Nancy P Mendenhall, Randal H Henderson, et al.Cancer Investigation|March 7, 2019
Serum Testosterone 60 Months after Passive-Scatter Proton Therapy for Localized Prostate CancerR Charles Nichols, Christopher G Morris, Curtis Bryant, et al.Health Physics|June 12, 2008
Data collection, processing, validation, and verificationDeborah L Martin, Jennifer L Hoff, Roger A Gard, et al.Plos One|October 11, 2012
High prevalence of posterior polymorphous corneal dystrophy in the Czech Republic; linkage disequilibrium mapping and dating an ancestral mutationPetra Liskova, Rhian Gwilliam, Martin Filipec, et al.Journal of the American College of Cardiology|June 1, 1988
Survival and cardiac event rates in the first year after emergency coronary angioplasty for acute myocardial infarctionR S Stack, R M Califf, T Hinohara, et al.International Journal of Particle Therapy|February 7, 2022
Insurance Approval for Definitive Proton Therapy for Prostate CancerWilliam M Mendenhall, Eric D Brooks, Stephanie Smith, et al.International Journal of Radiation Oncology, Biology, Physics|April 7, 2020
Hypofractionated Proton Therapy with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Trial from the University of Florida and Proton Collaborative GroupBradford S Hoppe, Romaine C Nichols, Stella Flampouri, et al.Acta Oncologica (Stockholm, Sweden)|September 18, 2014
A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancerThomas P Kole, R Charles Nichols, Song Lei, et al.Pageof 231